News
- Details
The Medsintez plant from Novouralsk (a part of the Ural pharmaceutical holding being created by the government of the Sverdlovsk region and the Yunona holding) is to launch manufacturing of the first Russian insulin this May.
- Details
On November 26, the NovouralskMedsintez plant (the Sverdlovsk region, a part of the Yunona holding) launched a shop to produce genetic engineered insulin required by patients with diabetes mellitus. The company can enter the top 5 of the largest global manufacturers.
The Only Russian Plant for Infusion Solutions, Medsintez, Has Been Launched in the Sverdlovsk Region
- Details
On July 18, the only Russian plant for infusion solutions, Medsintez, has been launched in the Sverdlovsk region. The Yunona holding began to construct the plant in July 2001 as part of the drug import substitution program and on behalf of the Governor of the Sverdlovsk region.
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130